AI-Driven Assessment of Fibrotic and Vascular Changes Correlates with Patient Outcomes in Idiopathic Pulmonary Fibrosis

• by Julien Guiot, Jonne Engelberts, Monique Henket, Benoit Ernst, Quentin Maloir, Renaud Louis, David A. Lynch, Stephen M. Humphries, Jean-Paul Charbonnier

• October 24, 2025

Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis

• by Cheng Jiang, Sihao Cui, Shixuan Hou, Min Chen, Qiuyan Huang, Xiangyu Zhang, Sijia Li, Deqin Yang, Mengshu Cao

• February 10, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

• by Paula Span

• February 4, 2026

• 7 min

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

• by Kathryn Wighton

• March 5, 2026

• 3 min